Starpharma Holdings Limited
(ASX:SPL) CEO Dr Jackie Fairley presents at the ASX Investor Series in Sydney.
The presentation outlines the company’s VivaGel portfolio, drug delivery and agrochemicals platforms and the potential for multiple and parallel revenue streams.
Dr Fairley details benefits of the company’s DEP docetaxel, what makes the VivaGel condom compelling and opportunities for using VivaGel for the prevention of recurrent bacterial vaginosis.
